Management of venous stenosis in living donor liver transplant recipients

被引:6
|
作者
Yang, Jie [1 ]
Xu, Ming-Qing [1 ]
Yan, Lu-Nan [1 ]
Lu, Wu-Sheng [1 ]
Li, Xiao [1 ]
Shi, Zheng-Rong [1 ]
Li, Bo [1 ]
Wen, Tian-Fu [1 ]
Wang, Wen-Tao [1 ]
Yang, Jia-Ying [1 ]
机构
[1] Sichuan Univ, W China Hosp, Dept Liver & Vasc Surg, Chengdu 610041, Sichuan, Peoples R China
关键词
Living donor liver transplantation; Venous obstruction; Anastomotic stenosis; Venoplasty; Stent; PORTAL-VEIN STENOSIS; PERCUTANEOUS TRANSHEPATIC VENOPLASTY; MIDDLE HEPATIC VEIN; OUTFLOW OBSTRUCTION; STENT PLACEMENT; BALLOON ANGIOPLASTY; TISSUE EXPANDER; RECONSTRUCTION; COMPLICATIONS; CHILDREN;
D O I
10.3748/wjg.15.4969
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To retrospectively evaluate the management and outcome of venous obstruction after living donor liver transplantation (LDLT). METHODS: From February 1999 to May 2009, 1 intraoperative hepatic vein (HV) tension induced HV obstruction and 5 postoperative HV anastomotic stenosis occurred in 6 adult male LDLT recipients. Postoperative portal vein (PV) anastomotic stenosis occurred in 1 pediatric left lobe LDLT. Patients ranged in age from 9 to 56 years (median, 44 years). An air balloon was used to correct the intraoperative HV tension. Emergent surgical reoperation, transjugular HV balloon dilatation with stent placement and transfemoral venous HV balloon dilatation was performed for HV stenosis on days 3, 15, 50, 55, and 270 after LDLT, respectively. Balloon dilatation followed with stent placement via superior mesenteric vein was performed for the pediatric PV stenosis 168 d after LDLT. RESULTS: The intraoperative HV tension was corrected with an air balloon. The recipient who underwent emergent reoperation for hepatic stenosis died of hemorrhagic shock and renal failure 2 d later. HV balloon dilatation via the transjugular and transfemoral venous approach was technically successful in all patients. The patient with early-onset HV stenosis receiving transjugular balloon dilatation and stent placement on the 15th postoperative day left hospital 1 A later and disappeared, while the patient receiving the same interventional procedures on the 50th postoperative day died of graft failure and renal failure 2 wk later. Two patients with late-onset HV stenosis receiving balloon dilatation have survived for 8 and 4 mo without recurrent stenosis and ascites, respectively. Balloon dilatation and stent placement via the superior mesenteric venous approach was technically successful in the pediatric left lobe LDLT, and this patient has survived for 9 mo without recurrent PV stenosis and ascites. CONCLUSION: Intraoperative balloon placement, emergent reoperation, proper interventional balloon dilatation and stent placement can be effective as a way to manage hepatic and PV stenosis during and after LDLT.
引用
收藏
页码:4969 / 4973
页数:5
相关论文
共 50 条
  • [11] Higher resource utilization in adult living donor liver transplant recipients compared to deceased donor liver transplant recipients.
    Conway, JD
    Russo, MW
    Johnson, M
    Shrestha, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 294 - 294
  • [12] Neurologic complications in adult living donor liver transplant recipients
    Kim, Bum-Soo
    Lee, Sung-Gyu
    Hwang, Shin
    Park, Kwang-Min
    Kim, Ki-Hun
    Ahn, Chul-Soo
    Moon, Deok-Bog
    Ha, Tae-Yong
    Song, Gi-Won
    Kim, Dong-Sik
    Moon, Ki-Myung
    Jung, Dong-Hwan
    CLINICAL TRANSPLANTATION, 2007, 21 (04) : 544 - 547
  • [13] Antibody elimination by apheresis in living donor liver transplant recipients
    Kawagishi, N
    Ohkohchi, N
    Fujimori, K
    Orii, T
    Koyamada, N
    Kikuchi, H
    Sekiguchi, S
    Tsukamoto, S
    Sato, T
    Satomi, S
    THERAPEUTIC APHERESIS, 2001, 5 (06): : 449 - 454
  • [14] Changes in Pancreas Volume in Living Donor Liver Transplant Recipients
    Brown, Cristal
    Ray, Callaghan
    Kuketz, Garrett
    Virostko, John
    TRANSPLANTATION, 2024, 108 (10) : e313 - e320
  • [15] Weaning of Immunosuppression in Living Donor Liver Transplant Recipients.
    Takatsuki, Mitsuhisa
    Soyama, Akihiko
    Torashima, Yasuhiro
    Ohno, Shinichiro
    Kinoshita, Ayaka
    Natsuda, Koji
    Fujii, Mio
    Adachi, Tomohiko
    Kitasato, Amane
    Kuroki, Tamotsu
    Eguchi, Susumu
    LIVER TRANSPLANTATION, 2013, 19 : S90 - S90
  • [16] No Benefit of Antithymocyte Globulin in Living Donor Liver Transplant Recipients
    Wilson, N.
    Nguyen, P.
    Saracino, G.
    Patel, R.
    Testa, G.
    Sam, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 775 - 775
  • [17] ELECTIVE WEANING OF IMMUNOSUPPRESSION IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS
    Takatsuki, Mitsuhisa
    Okada, Satomi
    Hidaka, Masaaki
    Soyama, Akihiko
    Natsuda, Koji
    Hara, Takanobu
    Adachi, Tomohiko
    Ono, Shinichiro
    Kanetaka, Kengo
    Eguchi, Susumu
    TRANSPLANT INTERNATIONAL, 2017, 30 : 453 - 453
  • [18] Posttransplant Bacteremia in Adult Living Donor Liver Transplant Recipients
    Iida, Taku
    Kaido, Toshimi
    Yagi, Shintaro
    Yoshizawa, Atsushi
    Hata, Koichiro
    Mizumoto, Masaki
    Mori, Akira
    Ogura, Yasuhiro
    Oike, Fumitaka
    Uemoto, Shinji
    LIVER TRANSPLANTATION, 2010, 16 (12) : 1379 - 1385
  • [19] Renal function after living donor liver transplant - Comparison with deceased donor liver transplant recipients.
    Pal, AK
    Douglas, DD
    Reddy, KS
    Heilman, RL
    Moss, AA
    Mulligan, DC
    Mazur, MJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 209 - 209
  • [20] Comparison of Pharmacokinetics of Mycophenolic Acid and Its Metabolites Between Living Donor Liver Transplant Recipients and Deceased Donor Liver Transplant Recipients
    Shen Baiyong
    Chen Bing
    Zhang Weixia
    Mao Huarong
    Shen Chuan
    Deng Xiaxing
    Zhan Xi
    Chen Hao
    LIVER TRANSPLANTATION, 2009, 15 (11) : 1473 - 1480